Shifts in mortality curves: Saving or extending lives?

Lancet

Volumn 354, Issue 9187, 1999, Pages 1378-1381

  Tan, L B ^a   Murphy, R ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Rose Hill   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT; ISOSORBIDE MONONITRATE; MAGNESIUM SULFATE; TRANDOLAPRIL;

ACUTE HEART INFARCTION; CLINICAL TRIAL; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SHORT SURVEY; STATISTICAL ANALYSIS; STROKE; SURVIVAL;

EID: 0033576142     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)11472-1     Document Type: Note

References (22)

1. Xamoterol in severe heart failure. Lancet. 336:1990;1-6.
2. Packer M., Leier C.V. Survival in congestive heart failure during treatment with drugs with positive inotropic actions. Circulation. 75:1987;55-63.
3. Packer M., Carver J.R., Rodeheffer R.J.et al. Effect of oral milrinone on mortality on mortality in severe chronic heart failure. N Engl J Med. 325:1991;1468-1475.
4. Packer M., Narahara K.A., Elkayam U.et al. Principle Investigators of REFLECT Study. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. J Am Coll Cardiol. 22:1993;65-72.
5. Elborn J.S., Stanford C.F., Nicholls D.P. Effect of flosequinan on exercise capacity and symptoms in severe heart falure. Br Heart J. 61:1989;331-335.
6. Bobbio M., Demichelis B., Giustetto G. Completeness of reporting trial results: effect on physicians' willingness to prescribe. Lancet. 343:1994;1209-1211.
7. Forrow L., Taylor W.C., Arnold R.M. Absolutely relative: how research results are summarized can affect treatment decisions. Am J Med. 92:1992;121-124.
8. Naylor C.D., Chen E., Strauss B. Measured enthusiasm: does the method of reporting trial results alter perception of therapeutic effectiveness? Ann Intern Med. 117:1992;916-921.
9. Huff D. How to lie with statistics. 1954;W W Norton & Co, New York.
10. Feinstein A.R. Tempest in a P-pot? Hypertension. 7:1985;313-318.
11. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet. 345:1995;669-685.
12. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. ii:1998;349-360.
13. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 304:1992;405-412.
14. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 316:1987;429-435.
15. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
16. Effect of enelapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
17. Stafford R.S., Saglam D., Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med. 157:1997;2460-2464.
18. Ferrier A., Bettencourt P., Cortez M., Araujo J.P., Cerquira-Gomes M. Angiotensin-converting enzyme inhibitors in heart failure: physicians' prescribing behaviour. J Card Fail. 3:1997;295-302.
19. Paul S.D., Kuntz K.M., Eagle K.A., Weinstein M.C. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure. Arch Intern Med. 154:1994;1143-1149.
20. Torp-Pedersen C., Kobler L. How much longer do patients with LV dysfunction after acute myocardial infarction live when related with angiotensin converting enzyme inhibitor. Circulation. 96:1997;90-91. (suppl I).
21. Swedberg K., Kjekshus J., Snapinn S. Long-term survival in severe heart failure in patients with enalapril: ten year follow-up of CONSENSUS I. Eur Heart J. 20:1999;136-139.
22. Yusuf S., Zucker D., Peduzzi P.et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Sugery Trialists Collaboration. Lancet. 344:1994;563-570.